The Food and Drug Administration has approved Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug's price.
The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.
Juul says new retail software successfully curbed underage purchases and wants all stores that sell its products to eventually use it, Bloomberg reports.
The catch: Retailers gripe about changing their check-out software for 1 product. The system locks up if there are bulk purchases or if an invalid ID is scanned.
The delay in implementing comprehensive regulations for e-cigarettes has contributed to a growing crisis of vaping-related illnesses and deaths across the U.S. and poses particular risks to young adults.
The big picture: E-cigarette use by American teenagers has surged, and the dangers are heightened by unsafe black market vaping devices and THC cartridges. But a recent flurry of regulatory activity by states looks set to continue, with federal action following shortly.
President Trump may be telling voters everything that they want to hear when it comes to health care, but much of it isn't true.
Why it matters: Trump is claiming victories he hasn't achieved and making promises he's not prepared to live up to, all on an immensely personal subject that voters consistently rank as one of the most important issues of 2020.
